A novel deep generative model for mRNA vaccine development: Designing 5' UTRs with N 1-methyl-pseudouridine modification

一种用于mRNA疫苗开发的新型深度生成模型:设计带有N1-甲基假尿苷修饰的5'非翻译区

阅读:2
作者:Xiaoshan Tang ,Miaozhe Huo ,Yuting Chen ,Hai Huang ,Shugang Qin ,Jiaqi Luo ,Zeyi Qin ,Xin Jiang ,Yongmei Liu ,Xing Duan ,Ruohan Wang ,Lingxi Chen ,Hao Li ,Na Fan ,Zhongshan He ,Xi He ,Bairong Shen ,Shuai Cheng Li ,Xiangrong Song

Abstract

Efficient translation mediated by the 5' untranslated region (5' UTR) is essential for the robust efficacy of mRNA vaccines. However, the N1-methyl-pseudouridine (m1Ψ) modification of mRNA can impact the translation efficiency of the 5' UTR. We discovered that the optimal 5' UTR for m1Ψ-modified mRNA (m1Ψ-5' UTR) differs significantly from its unmodified counterpart, highlighting the need for a specialized tool for designing m1Ψ-5' UTRs rather than directly utilizing high-expression endogenous gene 5' UTRs. In response, we developed a novel machine learning-based tool, Smart5UTR, which employs a deep generative model to identify superior m1Ψ-5' UTRs in silico. The tailored loss function and network architecture enable Smart5UTR to overcome limitations inherent in existing models. As a result, Smart5UTR can successfully design superior 5' UTRs, greatly benefiting mRNA vaccine development. Notably, Smart5UTR-designed superior 5' UTRs significantly enhanced antibody titers induced by COVID-19 mRNA vaccines against the Delta and Omicron variants of SARS-CoV-2, surpassing the performance of vaccines using high-expression endogenous gene 5' UTRs. Keywords: 5′ UTR; COVID-19; Machine learning; N1-Methyl-pseudouridine; SARS-CoV-2; Sequence design; mRNA design; mRNA vaccine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。